The United States Agency for International Development’s (USAID) Bureau for Global Health’s flagship Maternal and Child Survival Program (MCSP) is designed to advance USAID’s goal of Ending Preventable Child and Maternal Deaths, and is currently working in 25 countries.
MCSP supports the introduction and scale-up of high-impact, sustainable reproductive, maternal, newborn and child health (RMNCH) interventions in partnership with ministries of health and other partners. MCSP accepts all sources of health funds and can be accessed via field support. While MCSP is the principal follow-on to the Maternal and Child Health Integrated Program (MCHIP), the scope has expanded to reflect a changing global RMNCH landscape as well as shifts in USAID’s own priorities. MCSP places a greater emphasis on key cross-cutting issues such as innovation, e/mHealth, equity, quality, gender, public-private partnerships and involvement of civil society, community approaches, health systems strengthening, and behavior change interventions. While maintaining a focus on technical, high-impact interventions, MCSP works toward sustainable scale-up to include the health systems that deliver these interventions.
MCSP is a partnership led by Jhpiego, with Save the Children Federation, Inc., John Snow, Inc., ICF International, Results for Development Institute, PATH, CORE Group and PSI as lead partners and Broad Branch Associates, Johns Hopkins Bloomberg School of Public Health, Communications Initiative and Avenir Health as associate partners.
In addition to contributing to high-level technical and policy dialogue at the global level, MCSP provides tailored technical assistance to help countries meet specific priorities and contextual needs of local RMNCH programs, including:
Who: The Maternal and Child Survival Program (MCSP)
What: Five-year, $500 million cooperative agreement
When: Awarded March 2014
Where: A focus on 25 USAID high-priority countries
Why: To end preventable child and maternal deaths within a generation
*Updated August 2016